Friday, June 22, 2018

Global Midkine Market Research Report to 2018: Ken Research

According to the recently published report Midkine - Pipeline Review, H1 2018 Midkine (Amphiregulin Associated Protein or Midgestation and Kidney Protein or Neurite Outgrowth Promoting Factor 2 or MDK) pipeline Target constitutes close to 8 molecules. Out of which approximately 6 molecules are developed by companies and remaining by the universities/institutes.
Midkine (Amphiregulin Associated Protein or Midgestation and Kidney Protein or Neurite Outgrowth Promoting Factor 2 or MDK) - Midkine (MDK) or neurite growth-promoting factor 2 is a protein encoded by the MDK gene. It binds to anaplastic lymphoma kinase which induces ALK activation and subsequent phosphorylation of the insulin receptor substrate, activation of mitogen-activated protein kinase and PI3-kinase and the induction of cell proliferation. It is involved in neointima formation after arterial injury and early fetal adrenal gland development.

The report 'Midkine - Pipeline Review, H1 2018' outlays comprehensive information on the Midkine (Amphiregulin Associated Protein or Midgestation And Kidney Protein or Neurite Outgrowth Promoting Factor 2 or MDK) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type; that are being developed by Companies / Universities.

It also reviews key players involved in Midkine (Amphiregulin Associated Protein or Midgestation and Kidney Protein or Neurite Outgrowth Promoting Factor 2 or MDK) targeted therapeutics development with respective active and dormant or discontinued projects. Currently, the molecules developed by companies in Preclinical stages are 6 respectively. Similarly, the universities portfolio in Preclinical stages comprises 2 molecules, respectively. Report covers products from therapy areas Oncology, Genito Urinary System And Sex Hormones, Immunology, Metabolic Disorders, Gastrointestinal, Musculoskeletal Disorders, Cardiovascular and Respiratory which include indications Inflammation, Diabetic Nephropathy, Kidney Fibrosis, Liver Fibrosis, Non-Small Cell Lung Cancer, Acute Renal Failure (ARF) (Acute Kidney Injury), Autoimmune Disorders, Bone Disorders, Bone Fracture, Chronic Kidney Disease (Chronic Renal Failure), Fibrosis, Focal Segmental Glomerulosclerosis (FSGS), Glioblastoma Multiforme (GBM), Glomerulonephritis, Ischemia Reperfusion Injury, Kidney Disease, Lung Disease, Neuroblastoma, Osteoporosis, Osteosarcoma, Prostate Cancer, Solid Tumor and Squamous Non-Small Cell Lung Cancer.

The report provides a snapshot of the global therapeutic landscape for Midkine (Amphiregulin Associated Protein or Midgestation and Kidney Protein or Neurite Outgrowth Promoting Factor 2 or MDK)

The report reviews Midkine (Amphiregulin Associated Protein or Midgestation and Kidney Protein or Neurite Outgrowth Promoting Factor 2 or MDK) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

The report reviews key players involved in Midkine (Amphiregulin Associated Protein or Midgestation and Kidney Protein or Neurite Outgrowth Promoting Factor 2 or MDK) targeted therapeutics and enlists all their major and minor projects

The report assesses Midkine (Amphiregulin Associated Protein or Midgestation and Kidney Protein or Neurite Outgrowth Promoting Factor 2 or MDK) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type

The report summarizes all the dormant and discontinued pipeline projects
The report reviews latest news and deals related to Midkine (Amphiregulin Associated Protein or Midgestation and Kidney Protein or Neurite Outgrowth Promoting Factor 2 or MDK) targeted therapeutics

To know, more click on the link below:

Related Reports:

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
0124-4230204

Singapore Dental and Medical Clinics Market is Expected to Reach SGD 4.8 Billion by 2022: Ken Research



Key Takeaways from Ken Research report titled, Singapore Dental and Medical Clinic Market Outlook to 2022
·         Singapore clinics market is dominated by the private GP clinics which cater to 80% of the primary care demand in Singapore. Major clinics group include Singapore Medical Group, Q&M Dental, TalkMed Group, Singapore O&G, and Healthway Medical Corporation.
·         The market has witnessed the adoption of asset light model by leading clinics group which has enabled them to achieve higher growth rates and increase their cross selling opportunities within different specialization departments.

Ken Research in its latest study, “Singapore Medical and Dental Clinics Market Outlook to 2022 – Led by Inorganic Expansion of Major Clinics and Expansion into More Specialized Services suggests that demand for outpatient services in the market will continue to grow in Singapore owing to increased adoption of healthcare IT systems and rising investment by the private and public sector.

Expected Inorganic Growth in Future
Singapore clinics market will be led by an increase in mergers, acquisitions and joint ventures as large players acquire smaller clinics in order to expand their service portfolio. New Joint Ventures will lead to enhancing technical knowhow resulting in better quality service. The market will be driven by emergence of more specialized group which run on asset light model and rely heavily on growing number of doctors to leverage on economies of scale. Such developments will lead the market towards consolidation.

Increase Healthcare Service Practice and Scope of General Practitioners in Singapore
MOH has proposed methods for the prevention of diseases. Mental health services will be strengthened as polyclinics witness expansion to include mental health facilities. Further, MOH will roll out a scaled up primary care network scheme to provide more support encouraging more number of general practitioners to enter the space. Around 340 GP clinics have joined the Primary Care Network Scheme which involves clinics organizing themselves into networks that support holistic and team-based care. GPs in PCNs are able to share and optimize resources, and they can also share best practices among themselves to better manage care of chronic diseases.

Government Support to open More Primary Care Units
MOH will open more primary care facilities. Keat Hong and Tampines family medicine clinics are to open in 2018 followed by new polyclinics in Pioneer, Punggol and Bedok. New polyclinics in Bukit Panjang, Eunos, Sembawang and Kallang will begin operation in 2020 while those in Yishun and Ang Mo Kio will be redeveloped in 2018. Participation in electronic records system could become a licensing requirement for clinics. This will help in improving the quality of health care services.

Future Growth Factors
Rising focus on high revenue intensity streams along with general OPD services which includes offering specialized services and comprehensive health screening programs coupled with elevating prevalence of chronic and lifestyle diseases will propel Singapore clinics market revenue in future.

Companies Covered: Singapore Medical Group, Q&M Dental Group, ISEC Healthcare, TalkMed, Singapore O&G, Healthway Medical Corporation, HC Surgical Specialists Limited and Unity Denticare

For more information on the research report, refer to below link:

Related Reports by Ken Research:



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
Sales@kenresearch.com
+91-9015378249

Acyl CoA Desaturase Market Outlook: Ken Research

Acyl CoA Desaturase (Fatty Acid Desaturase or Delta 9 Desaturase or Stearoyl CoA Desaturase or SCD or EC 1.14.19.1) - Stearoyl-CoA desaturase 1 is a protein encoded by the SCD gene. Stearoyl-CoA desaturase-1 plays an important enzyme in fatty acid metabolism. Alteration in SCD1 expression changes the fatty acid profile of these lipids and produces diverse effects on cellular function.

High SCD1 expression is correlated with metabolic diseases such as obesity and insulin resistance, whereas low levels are protective against these metabolic disturbances. SCD1 is also involved in the regulation of inflammation and stress in distinct cell types, including?-cells, adipocytes, macrophages, endothelial cells, and myocytes. Complete loss of SCD1 expression has been implicated in liver dysfunction and several inflammatory diseases such as dermatitis, atherosclerosis, and intestinal colitis.

Acyl CoA Desaturase (Fatty Acid Desaturase or Delta 9 Desaturase or Stearoyl CoA Desaturase or SCD or EC 1.14.19.1) pipeline Target constitutes close to 5 molecules. The molecules developed by companies in Phase III, Preclinical, Discovery and Unknown stages are 1, 2, 1 and 1 respectively. Report covers products from therapy areas Gastrointestinal, Oncology and Central Nervous System which include indications Non-Alcoholic Steatohepatitis (NASH), Colorectal Cancer, Liver Fibrosis, Metastatic Renal Cell Carcinoma, Non Alcoholic Fatty Liver Disease (NAFLD) and Osteoarthritis Pain.

The latest report Acyl CoA Desaturase - Pipeline Review, H1 2018, outlays comprehensive information on the Acyl CoA Desaturase (Fatty Acid Desaturase or Delta 9 Desaturase or Stearoyl CoA Desaturase or SCD or EC 1.14.19.1) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews key players involved in Acyl CoA Desaturase (Fatty Acid Desaturase or Delta 9 Desaturase or Stearoyl CoA Desaturase or SCD or EC 1.14.19.1) targeted therapeutics development with respective active and dormant or discontinued projects.

The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.
The report provides a snapshot of the global therapeutic landscape for Acyl CoA Desaturase (Fatty Acid Desaturase or Delta 9 Desaturase or Stearoyl CoA Desaturase or SCD or EC 1.14.19.1)

The report reviews Acyl CoA Desaturase (Fatty Acid Desaturase or Delta 9 Desaturase or Stearoyl CoA Desaturase or SCD or EC 1.14.19.1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

The report reviews key players involved in Acyl CoA Desaturase (Fatty Acid Desaturase or Delta 9 Desaturase or Stearoyl CoA Desaturase or SCD or EC 1.14.19.1) targeted therapeutics and enlists all their major and minor projects

The report assesses Acyl CoA Desaturase (Fatty Acid Desaturase or Delta 9 Desaturase or Stearoyl CoA Desaturase or SCD or EC 1.14.19.1) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type

The report summarizes all the dormant and discontinued pipeline projects
The report reviews latest news and deals related to Acyl CoA Desaturase (Fatty Acid Desaturase or Delta 9 Desaturase or Stearoyl CoA Desaturase or SCD or EC 1.14.19.1) targeted therapeutics

To know, more click on the link below:

Related Reports:

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
0124-4230204

The Green Future of Real Estate Market Outlook: Ken Research

Real estate is a constantly growing market which is a very prominent part of a country’s economy. Technology trends have shaped this market well and are constantly trying to attract more customers. In recent times there has been rampant growth but this has only been myopic and concerns are now being raised about the effects of this industry on the environment. Market research reports for real estate appears to support the theory that the countries and economies that are actively incorporating eco friendly operational methods are being counted among the most developed in the world.
Real estate has mainly been driven by innovation and the quest of economies to attract foreign investments. Technology is working to improve customer experience and eco friendly innovations are also taking place. Real estate industry research reports are revealing an increase in global demand for environment friendly infrastructure. Many developed countries are basing their developments on this demand. Research into new designs and layouts is exploring ways to recycle waste water and minimize polluting emissions. Modern technology is also being used to check credibility of construction projects. Today any real estate development project has to undergo a number of certifications and credibility checks to ensure the project is in line with environmental standards. Awareness via social media and the internet is rising and people too have begun considering environmental certifications as a way to check soundness of real estate properties. This is putting an ever increasing pressure on the real estate industry and government. Authorities are now taking measures to align their operations with environment conservation. Countries that are successfully incorporating environmental concern into their real estate prospects are preferred by people and this reflects in factors like trade, strength of currency and price of real estate.
Concept of green homes is widespread today and families are becoming more aware about the importance of such infrastructure. Builders and big companies are also incorporating this concept as the base for their future developments.
Real estate agents with Green Designation should be consulted. This designation is growing in popularity among educational institutions and career development processes. Some of these designations available are EcoBroker Certified Designations, Leadership in Energy and Environment Design and Earth Advantage Sustainability Training.
The hospitality industry is also innovating and altering its operations to incorporate more and more eco friendly methods. The reputation of those who do so is quite good among customers thereby proving that such real estate directly translates into profitable prospects.
There are several companies who have begun to realize the importance of eco friendly real estate however there are some companies who have more actively invested in this sector. Delos Living is rampantly developing on the concept of green homes and their efforts are paying off as they are now among the leaders in wellness real estate. Big giants of the hospitality industry are also taking steps in this direction. Hotels such as the Best Western Chill worth Manor, the Fairmont Hotels and Resorts and the Palace hotel are all UK based leaders in sustainability.
Green real estate is the future of real estate development evident by presence of big giants like Delos Living who specialize in the field. Varied industries like the hospitality industry are participating in the efforts. UK has emerged at the forefront of these developments alongside Singapore and the United States.
Key Topics Covered in the Report
Real Estate Market Research Reports
Real Estate Industry Analysis
Market Research Reports for Real Estate
Real Estate Industry Research Report
Real Estate Market Research Reports Consulting
Real Estate Business Review
Real Estate Industry Research and Market Reports
For more information on the research report, refer to below link:
Contact:              
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-124-4230204

Thursday, June 21, 2018

Eco-friendly Multipack Shrink Films to Control Plastic Multipack Shrink Films in Asia : Ken Research


According to the study Asia Beverage Multipack Shrink Film Industry Situation and Prospects Research report, multipack shrink film packaging is light-weight, durable and visually attractive. When compared to rigid packaging, multipack shrink films lessen the conveyance expenditures of beverages and are easier to carry. The growing consumption of alcoholic beverages and demand for ready-to-drink fruit juices are the two major factors driving the growth of Asia beverages multipack shrink films market. The various types of beverage multipack shrink films that are commercially available are polyethylene, polypropylene, polyvinyl chloride and others. Multipack beverages are usually packed in cans or bottles with various designs. Water and carbonated soft drinks are the major multipack beverages that demand for multipack shrink films as secondary packaging due ever growing demand for these products. The various types of shrink films are printed and unprinted shrink films. The most commonly used film is the printed shrink film wrap that is used in almost all industries, especially where retail point-of-sale is concerned.
Secondary packaging in beverages is more important for major beverage brands because the competition for them begins on the shelf. Asian consumers decide the beverage products based on the kind of packaging which is a great opportunity for beverage manufacturers to keep themselves updated with the latest packaging products. Packaging innovations maintains beverage sales and looks for newer ways to attract the consumers. Beverage multipacks provide an aesthetic appeal, enhanced brand visibility, facilitate easy transport and consumption. Beverage multipack shrink film market is growing rapidly due to the rise in the middle class population and increase in consumer disposable income. It was observed that there is an increasing demand for alternative beverages such as organic juices, enhanced water & functional beverages which drive the growth in beverage multipack shrink film market.
Multipack shrink films are used for wrapping up a group of several containers or bottles together in order to sell it as a single unit. The packing consists of various containers of dissimilar shapes and sizes such as water, milk, alcoholic drinks, soft drinks, dairy products and ready to drink products such as tea, coffee, health drinks, sports drinks, and dairy beverages. Use of multipack shrink films help in conserving the environment by reducing use of more plastic. Multipack shrink films market in Asia is regulated and controlled by both established as well as small emerging players.
Geographically, Asia beverage multipack shrink film industry is spread across China, Japan, South Korea, Taiwan, India, Southeast Asia and Australia. The leading players in Asia beverage multipack shrink film industry are Berry Plastics Corporation, Sealed Air Corporation, Bemis Company, Coveris Holdings, Reynolds, Sigma Plastics, Clondalkin, Polyrafia, Crayex Corporation, Tri-Cor, Amcor Limited and RKW.
Asia’s drastic industrial development has led to a huge demand for shrink films that are used as beverage multipacks materials. Almost all the major players involved in beverage multipack shrink film market are concentrating on R&D initiatives to develop new products to cater the increasing needs of customers. Consumers in Asia are anticipating a drastic growth over the next few years in beverage multipack shrink film market due to the need for attractive packaging in beverages industry and to increase sales of multi-bottle packages. The recyclability of plastics poses a serious risk to the environment which is one major reason hampering Asia’s beverage multipacks shrink film market. Asian multipack shrink film manufacturers are promoting eco-friendly packaging for beverage multipacks to conserve the environment.
For more information, click on the link below:
Related Report  : -
Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
0124-4230204


Singapore Medical and Dental Clinics Market Outlook to 2022-Ken Research

The report titled “Singapore Medical and Dental Clinics Market Outlook to 2022 – Led by Inorganic Expansion of Major Clinics and Expansion into More Specialized Servicescovers dental and medical clinics market segment by region, growth driver, restraints, government regulations, competitive landscape of major players in the Singapore clinics market including Singapore Medical Group, Q&M Dental Group, ISEC Healthcare, TalkMed, Singapore O&G, Healthway Medical Corporation, HC Surgical Specialists Limited and Unity Denticare. The report concludes with market projections for future and analyst recommendations highlighting the major opportunities and cautions.

Singapore Clinics Market Overview
Singapore clinics market inclined at a positive CAGR during 2013 to 2017. The market is at a growing stage with major clinic groups undertaking inorganic methods of expansion and widening their service portfolio. The demand for primary healthcare services has increased due to increase in ageing population and increasing chronic diseases prevalence. Diabetes, hypertension, hyperlipidaemia were the top chronic conditions treated at clinics during the review period. Clinics in Singapore provide primary healthcare services at subsidized rates under CHAS Scheme which includes primary medical treatment, preventive healthcare and health education.

Singapore Clinic Market Segmentation
By Type of Clinic: Medical clinics have accounted for the largest share in the overall Singapore Clinics market revenue in 2017. This is majorly driven by organic and inorganic expansion of large players and adoption of asset light model. Other types of clinics include dental clinics.
By Region: Majority of the clinics are located in the central and north region of Singapore driven by high population, and greater connectivity with other parts of Singapore. Within this region Woodlands and Yishun have the most number of clinics offering dental and family medicine.

Singapore Clinics Market Competition Overview
The clinics market is dominated by private GP clinics which meet majority of the total primary care demand in Singapore. These range from solo practices to medium and large corporate groups. The market has witnessed a rise in number of mergers and acquisitions and major clinics have increased their specialized doctor personnel in order to enter into new medical segments. Leading clinics groups have adopted asset light model in order to attain higher growth rates. Major competition parameters include geographic presence, services offered, doctor personnel, facilities and price.

Singapore Clinics Market Future Potential
The clinics market in Singapore is expected to grow at a double digit CAGR during 2017 to 2022. The market will be driven by emergence of more specialized group which run on asset light model and rely heavily on growing number of doctors to leverage on economies of scale. This will further enhance cross selling opportunities within the group. Such developments will lead to consolidation. Further, the organic growth of the private healthcare sector is expected to improve in the coming years as major players shift focus to offering specialized services. Participation in electronic records system could become a licensing requirement for clinics. This will help in improving the quality of health care services.

For more information on the research report, refer to below link:

Related Reports by Ken Research:



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
Sales@kenresearch.com
+91-9015378249

Emergence Of Ai In Education Industry Market Outlook : Ken Research


The introduction of artificial intelligence in technology has proved to be disruptive in almost all industries. Major impact of this technology is witnessed by the education sector. This disruptive technology is being integrated into the education industry at both institutional and course level. The Education Business Review suggests that global artificial intelligence market in education sector is expected to grow at a CAGR of 43.5% during the period of 2018-2022. The applications of this technology in this sector are innumerable. From making education more accessible to students with computers or smart devices to enabling organizations to reduce the time spent on tedious tasks and increasing the time spent on each student, this technology has revolutionized this market.
Artificial intelligence has great potential in automation and reducing the amount of time on administrative tasks. As education moves away from a rote learning to more dynamic modes the concept of learn-as-you-like especially among remote learning courses has emerged. Entire courses via virtual modes can be delivered via this technology and can even reply to certain standardized queries relating to the course. The most tedious and time consuming tasks the teachers have to go throw is grading. This is a major zone where the AI can assist organizations. Currently, AI technology powered devices are capable of grading only objective answer sheets but as AI develops, it shall soon be able to assess subjective answer sheets as well. Artificial intelligence powered bots have been introduced in Georgia Tech University, where bots reply to certain common and pre determined questions without the students knowing that they do not communicate with a human being. The AI is capable of finding gaps in the curriculum based on how students actually perform in the tests. For instance is most of the students are not able to answer a particular type or question, the AI will correlate that to the curriculum and find whether the particular topic was actually missing from the course or not. It shall then assist teachers to provide better student material or learning techniques. This technology can monitor student performance indicating key weak areas where students lack performance and convey this record to the teacher who in turn can focus their attention to these weak areas. Education Market Research Reports Consulting is of the view that today every kind of student from advance students to students with special needs requires access to same kind of education. Keeping this in mind, AI can adapt to individual student requirements making learning a lot more meaningful experience for the students.
The AI technology introduced in Georgia tech university (USA) has been backed by IBM’s technology. Some established companies working under this domain are Microsoft, Quantum Solutions, Pixatel, and Nuance Communications. Many new startups have gained entry into the booming industry such as elemental path, querium corporation, metacog, jellynote and fishtree. The competition in this sector is expected to remain tense due to a high CAGR with startups trying to gain a piece of the market share.
The institutions across the globe are witnessing the future of the education industry due to the introduction of this advanced technology. It is expected to improve the way lectures are conducted in classrooms and reduce administrative tasks considerably. Plus, this technology will save millions in cost for institutions and allow them to appropriate its fund to key matters paving the way for operational effectiveness and efficiency.
For more information, click on the link below:
Related Report  : -
Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
0124-4230204